Latest Insider Transactions at Adtran Inc (ADTN)
This section provides a real-time view of insider transactions for Adtran Inc (ADTN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ADTRAN INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ADTRAN INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 08
2022
|
Balan Nair |
SELL
Grant, award, or other acquisition
|
Direct |
74,188
-50.0%
|
-
|
|
Jul 08
2022
|
Gregory James Mc Cray |
BUY
Grant, award, or other acquisition
|
Direct |
21,641
+50.0%
|
-
|
|
Jul 08
2022
|
H Fenwick Huss |
BUY
Grant, award, or other acquisition
|
Direct |
56,415
+50.0%
|
-
|
|
Jul 08
2022
|
Michael Foliano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
247
+50.0%
|
-
|
|
Jul 08
2022
|
Michael Foliano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,241
+50.0%
|
-
|
|
Jul 08
2022
|
James Denson Wilson Jr Chief Revenue Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
4,117
-100.0%
|
-
|
|
Jul 08
2022
|
James Denson Wilson Jr Chief Revenue Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
54,015
-100.0%
|
-
|
|
Jul 08
2022
|
Kathryn A Walker |
SELL
Sale (or disposition) back to the issuer
|
Direct |
47,478
-100.0%
|
-
|
|
Jul 08
2022
|
Thomas R Stanton Chairman & CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
305,558
-100.0%
|
-
|
|
Jul 08
2022
|
Hourigan Rice Jacqueline |
SELL
Sale (or disposition) back to the issuer
|
Direct |
39,311
-100.0%
|
-
|
|
Jul 08
2022
|
Balan Nair |
SELL
Sale (or disposition) back to the issuer
|
Direct |
74,188
-100.0%
|
-
|
|
Jul 08
2022
|
Gregory James Mc Cray |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,641
-100.0%
|
-
|
|
Jul 08
2022
|
Marc Kimpe SVP, Research & Development |
SELL
Sale (or disposition) back to the issuer
|
Direct |
27,526
-100.0%
|
-
|
|
Jul 08
2022
|
H Fenwick Huss |
SELL
Sale (or disposition) back to the issuer
|
Direct |
56,415
-100.0%
|
-
|
|
Jul 08
2022
|
Ray Harris Chief Information Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
16,551
-100.0%
|
-
|
|
Jul 08
2022
|
Michael Foliano Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
247
-100.0%
|
-
|
|
Jul 08
2022
|
Michael Foliano Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
52,912
-100.0%
|
-
|
|
Jul 08
2022
|
Robert Conger SVP, Technology & Strategy |
SELL
Sale (or disposition) back to the issuer
|
Direct |
18,155
-100.0%
|
-
|
|
Jul 08
2022
|
Ronald Centis SVP, Operations |
SELL
Sale (or disposition) back to the issuer
|
Direct |
27,803
-100.0%
|
-
|
|
Jun 03
2022
|
Gregory James Mc Cray |
BUY
Grant, award, or other acquisition
|
Direct |
35
+0.16%
|
$665
$19.33 P/Share
|
|
Jun 03
2022
|
James Denson Wilson Jr Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120
+0.22%
|
$2,280
$19.33 P/Share
|
|
Jun 03
2022
|
Thomas R Stanton Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
349
+0.11%
|
$6,631
$19.33 P/Share
|
|
Jun 02
2022
|
Michael Foliano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
1
+0.4%
|
$17
$17.98 P/Share
|
|
Jun 02
2022
|
James Denson Wilson Jr Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
18
+0.44%
|
$306
$17.98 P/Share
|
|
Jun 02
2022
|
Marc Kimpe SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
42
+0.15%
|
$756
$18.69 P/Share
|
|
Jun 02
2022
|
Ray Harris Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.07%
|
$198
$18.69 P/Share
|
|
Jun 02
2022
|
Robert Conger SVP, Technology & Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
28
+0.15%
|
$504
$18.69 P/Share
|
|
Jun 02
2022
|
Ronald Centis SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
44
+0.16%
|
$792
$18.69 P/Share
|
|
May 11
2022
|
Ronald Centis SVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
844
-2.95%
|
$16,880
$20.65 P/Share
|
|
May 11
2022
|
Ronald Centis SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
2,875
+9.13%
|
-
|
|
May 11
2022
|
Gregory James Mc Cray |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,308
-39.88%
|
$243,236
$17.94 P/Share
|
|
Mar 08
2022
|
Michael Foliano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
64
+0.12%
|
$1,216
$19.8 P/Share
|
|
Mar 08
2022
|
Gregory James Mc Cray |
BUY
Grant, award, or other acquisition
|
Direct |
34
+0.09%
|
$646
$19.8 P/Share
|
|
Mar 08
2022
|
Thomas R Stanton Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
339
+0.11%
|
$6,441
$19.8 P/Share
|
|
Mar 08
2022
|
James Denson Wilson Jr Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct |
117
+0.22%
|
$2,223
$19.8 P/Share
|
|
Mar 03
2022
|
Ronald Centis SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
30
+0.12%
|
$600
$20.48 P/Share
|
|
Mar 03
2022
|
Ray Harris Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10
+0.06%
|
$200
$20.48 P/Share
|
|
Mar 03
2022
|
Marc Kimpe SVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
38
+0.14%
|
$760
$20.48 P/Share
|
|
Mar 03
2022
|
Robert Conger SVP, Technology & Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
26
+0.14%
|
$520
$20.48 P/Share
|
|
Mar 03
2022
|
James Denson Wilson Jr Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
17
+0.41%
|
$306
$18.47 P/Share
|
|
Mar 03
2022
|
Michael Foliano Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
1
+0.4%
|
$18
$18.46 P/Share
|
|
Feb 25
2022
|
Ronald Centis SVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
174
-0.67%
|
$3,480
$20.65 P/Share
|
|
Feb 24
2022
|
Marc Kimpe SVP, Research & Development |
SELL
Open market or private sale
|
Direct |
5,000
-15.41%
|
$100,000
$20.02 P/Share
|
|
Feb 24
2022
|
Marc Kimpe SVP, Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+13.35%
|
$80,000
$16.97 P/Share
|
|
Jan 18
2022
|
Ray Harris Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
122
-0.73%
|
$2,318
$19.15 P/Share
|
|
Dec 31
2021
|
H Fenwick Huss |
BUY
Grant, award, or other acquisition
|
Direct |
3,943
+6.54%
|
-
|
|
Dec 31
2021
|
H Fenwick Huss |
SELL
Sale (or disposition) back to the issuer
|
Direct |
0
|
$0
$22.83 P/Share
|
|
Dec 31
2021
|
H Fenwick Huss |
BUY
Exercise of conversion of derivative security
|
Direct |
114
+0.22%
|
-
|
|
Dec 31
2021
|
Gregory James Mc Cray |
BUY
Grant, award, or other acquisition
|
Direct |
3,943
+9.91%
|
-
|
|
Dec 31
2021
|
Gregory James Mc Cray |
SELL
Sale (or disposition) back to the issuer
|
Direct |
0
|
$0
$22.83 P/Share
|